NuPulseCV
Raleigh, US · Delaware corporation · 1 known investors
NuPulse Voyage is a cardiac support device designed to help heart transplant candidates improve their physical condition while awaiting transplantation. The device enables patients to remain mobile and active during the waiting period, potentially enhancing their candidacy for transplant.
Founders & leadership
GS
GREG SCOTTDirector
RS
RICHARD SHERMANDirector
AS
ALEX SHLYANKEVICHDirector
SP
SONNA PATEL-RAMANExecutive Officer
DA
DOUGLAS ALTSCHULERExecutive Officer, Director
BN
BRIAN NOVAKDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$2.1MraisedMar 2020 · 2 investors · BiotechnologyRule 506(b)
▶$2.1MraisedMar 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Douglas AltschulerExecutive Officer, Director
- Richard ShermanDirector
- Brian NovackDirector
- Alex ShlyankevichDirector
- Greg ScottDirector
- Dirk SimmonsDirector
- Sonna Patel-RamanExecutive Officer
- Offering amount
- $20M
- Amount sold
- $2.1M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.4MraisedJul 2018 · 13 investors · BiotechnologyRule 506(b)
▶$5.4MraisedJul 2018 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- GREG SCOTTDirector
- RICHARD SHERMANDirector
- ALEX SHLYANKEVICHDirector
- SONNA PATEL-RAMANExecutive Officer
- DOUGLAS ALTSCHULERExecutive Officer, Director
- BRIAN NOVAKDirector
- Offering amount
- $25M
- Amount sold
- $5.4M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.